US Broker Ratings

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating Growth in Health Information Services

Investors seeking opportunities in the dynamic healthcare sector may want to keep an eye on Weave Communications, Inc. (NASDAQ: WEAV). With a market capitalization of $594.53 million, this Lehi, Utah-based..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Navigating Biotech Growth with 65.7% Revenue Upsurge

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a prominent player in the biotechnology sector, has captured investor attention with an impressive 65.7% revenue growth. Specializing in innovative cell therapies, Iovance is strategically..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Exploring a Biotech Gem with a 70.81% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a clinical-stage biotechnology company, is attracting significant attention in the healthcare sector, particularly among investors with an eye for high-growth opportunities. With a market capitalization..

Neuropace, Inc. (NPCE) Stock Analysis: Exploring a 61.42% Upside Potential Amid Robust Buy Ratings

Neuropace, Inc. (NASDAQ: NPCE), a pioneering medical device company specializing in innovative treatments for drug-resistant focal epilepsy, has captured the attention of investors with its promising growth potential. Headquartered in..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring the 85% Potential Upside in Biotechnology

Arvinas, Inc. (NASDAQ: ARVN) presents a compelling opportunity for investors seeking exposure to the biotechnology sector, particularly those interested in innovative approaches to disease treatment. With a robust market cap..

STAAR Surgical Company (STAA)

⚠️ No article content returned.

..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 40% Potential Upside in the Healthcare Sector

Nutex Health Inc. (NASDAQ: NUTX), a prominent player in the healthcare sector, has caught the eye of investors with its unique business model and promising stock performance metrics. Headquartered in..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

Community Health Systems, Inc. (CYH) Investor Outlook: Navigating a 13% Upside Amidst Healthcare Sector Volatility

Community Health Systems, Inc. (NYSE: CYH) operates as a pivotal player in the healthcare sector, particularly within the medical care facilities industry in the United States. With a market capitalization..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Promising 29.68% Upside with Robust Revenue Growth

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a key player in the healthcare sector, is gaining traction among investors, particularly in the niche market of rare disease treatments. With a market capitalization..

Akso Health Group (AHG) Investor Outlook: Navigating Challenges with a 52-Week High of $2.50

Akso Health Group (NASDAQ: AHG) operates in the dynamic healthcare sector as a medical distribution company headquartered in Qingdao, China. With a market capitalization of $976.64 million, Akso Health Group..

Sionna Therapeutics, Inc. (SION) Investor Outlook: Unpacking a 328.57% Potential Upside

Sionna Therapeutics, Inc. (NASDAQ: SION) has caught the attention of investors with its striking 328.57% potential upside as indicated by the average target price set by analysts. For a company..

Cogent Biosciences (COGT) Stock Analysis: A Biotech Gem with 85.57% Potential Upside

Cogent Biosciences, Inc. (NASDAQ: COGT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of precision therapies aimed at genetically defined diseases...

Kura Oncology, Inc. (KURA) Investor Outlook: Unpacking a Potential 202% Upside in the Biotech Sphere

Kura Oncology, Inc. (NASDAQ: KURA) is capturing the attention of investors with its compelling growth potential in the biotechnology sector. As a clinical-stage biopharmaceutical company, Kura is focused on developing..

AxoGen, Inc. (AXGN) Stock Analysis: Robust Buy Ratings and a 48.75% Upside Potential

AxoGen, Inc. (NASDAQ: AXGN), a pioneer in the healthcare sector specializing in medical devices for peripheral nerve repair, presents a compelling investment opportunity with its promising growth trajectory and robust..

Spyre Therapeutics, Inc. (SYRE): A 50% Upside Potential in Innovative Biotech Solutions

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing the attention of investors with its promising pipeline in the biotechnology sector, particularly in the treatment of inflammatory bowel disease (IBD) and rheumatic..

InMode Ltd. (INMD) Stock Analysis: A Look at Growth Potential Amidst Stagnant Revenue

InMode Ltd. (NASDAQ: INMD) has carved a niche in the healthcare sector, particularly within the medical devices industry. The Israel-based company is renowned for its innovative aesthetic medical products, leveraging..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Analyzing a 25.10% Potential Upside in the Pediatric Medical Devices Sector

OrthoPediatrics Corp. (NASDAQ: KIDS) presents a compelling opportunity for investors keen on the healthcare sector, specifically within the niche market of pediatric orthopedic medical devices. With a market capitalization of..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a Potential 149% Upside

Investors with a keen eye on the biotechnology sector might find Bicycle Therapeutics plc (NASDAQ: BCYC) an intriguing prospect, especially given its substantial potential upside of 149.34%. This UK-based clinical-stage..

Collegium Pharmaceutical, Inc. (COLL) Investor Outlook: Unveiling a Promising 121.62% Potential Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a notable entity in the healthcare sector specializing in drug manufacturing, is catching the attention of savvy investors with its impressive potential upside of 121.62%...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds